3GV-79096-47669
3 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 180 / PA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Registered in v-safe
- 2020-12-22
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-18
Survey response — day 7, dose 2MedDRA: Pyrexia — Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessFree text: FeverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-02-03
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-04-14
- 2021-07-14
-
2021-11-09
Dose 3 — Moderna
- 2021-12-09
- 2021-12-15
- 2021-12-21
- 2022-02-08
- 2022-05-10
- 2022-11-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-11-09 | Moderna | No |
Free text
Release 2 — day 7, dose 2
Systemic reaction (other): Fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release